Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials

Guardado en:

Detalles Bibliográficos
Autores principales:	Hong Huang, Wenhui Xie, Zhuoli Zhang, Siyan Zhan
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/6e711cd71d0e411ebacc98873e930217
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6e711cd71d0e411ebacc98873e930217
record_format	dspace
spelling	oai:doaj.org-article:6e711cd71d0e411ebacc98873e9302172021-12-02T04:00:05ZRisk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials10.1136/lupus-2021-0005342053-8790https://doaj.org/article/6e711cd71d0e411ebacc98873e9302172021-10-01T00:00:00Zhttps://lupus.bmj.com/content/8/1/e000534.fullhttps://doaj.org/toc/2053-8790Hong HuangWenhui XieZhuoli ZhangSiyan ZhanBMJ Publishing GrouparticleImmunologic diseases. AllergyRC581-607ENLupus Science and Medicine, Vol 8, Iss 1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Immunologic diseases. Allergy RC581-607
spellingShingle	Immunologic diseases. Allergy RC581-607 Hong Huang Wenhui Xie Zhuoli Zhang Siyan Zhan Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
format	article
author	Hong Huang Wenhui Xie Zhuoli Zhang Siyan Zhan
author_facet	Hong Huang Wenhui Xie Zhuoli Zhang Siyan Zhan
author_sort	Hong Huang
title	Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
title_short	Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
title_full	Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
title_fullStr	Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
title_full_unstemmed	Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
title_sort	risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/6e711cd71d0e411ebacc98873e930217
work_keys_str_mv	AT honghuang riskofpsychiatricdisordersandallcausemortalitywithbelimumabtherapyinpatientswithsystemiclupuserythematosusametaanalysisofrandomisedcontrolledtrials AT wenhuixie riskofpsychiatricdisordersandallcausemortalitywithbelimumabtherapyinpatientswithsystemiclupuserythematosusametaanalysisofrandomisedcontrolledtrials AT zhuolizhang riskofpsychiatricdisordersandallcausemortalitywithbelimumabtherapyinpatientswithsystemiclupuserythematosusametaanalysisofrandomisedcontrolledtrials AT siyanzhan riskofpsychiatricdisordersandallcausemortalitywithbelimumabtherapyinpatientswithsystemiclupuserythematosusametaanalysisofrandomisedcontrolledtrials
_version_	1718401494508634112

Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials

Ejemplares similares